Showing results (1-10 of 137) with videos related to
Sort By:
Pageof 14
Nature Protocols|April 5, 2007
COBRA: combined binary ratio labeling of nucleic-acid probes for multi-color fluorescence in situ hybridization karyotypingKaroly Szuhai, Hans J TankeThe Journal of Pathology|September 7, 2012
'The chicken or the egg?' dilemma strikes back for the controlling mechanism in chordoma(#)Karoly Szuhai, Pancras C W HogendoornSurgical Pathology Clinics|August 12, 2017
Notochordal Tumors: An Update on Molecular Pathology with Therapeutic ImplicationsTakehiko Yamaguchi, Hiroki Imada, Shun Iida, et al.International Journal of Molecular Sciences|July 21, 2015
Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic LandscapesLaurens G L Sand, Karoly Szuhai, Pancras C W HogendoornExpert Review of Molecular Diagnostics|July 6, 2021
Gene fusions in vascular tumors and their underlying molecular mechanismsSheena L M Ong, Karoly Szuhai, Judith V M G BovéeNucleic Acids Research|July 24, 2002
Real-time monitoring of rolling-circle amplification using a modified molecular beacon designMats Nilsson, Mats Gullberg, Fredrik Dahl, et al.American Journal of Medical Genetics. Part A|May 17, 2007
Interstitial deletion of 6q without phenotypic effectKerstin Hansson, Karoly Szuhai, Jeroen Knijnenburg, et al.Cancer Immunology, Immunotherapy : CII|July 3, 2016
Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapyLaurens G L Sand, Dagmar Berghuis, Karoly Szuhai, et al.Virchows Archiv : an International Journal of Pathology|November 16, 2019
Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastomaSanne Venneker, Karoly Szuhai, Pancras C W Hogendoorn, et al.Cancers|December 2, 2020
Unraveling the Resistance of IGF-Pathway Inhibition in Ewing SarcomaStefanie de Groot, Bas Röttgering, Hans Gelderblom, et al.Pageof 14